Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative IV Glutamine in Cardiac Surgery
NCT01794884Phase 2Completed
- Start
- Jan 2013
- Primary completion
- Mar 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alanyl glutamine in rheumatic heart disease (RHD) and coronary heart disease (CHD) (2 arms). Primary endpoint: Cardiac Index. Started Jan 2013; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
rheumatic heart disease (RHD)coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT01794884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794884.